$45.39
Value $6.1B
EnactvsMorgan Stanley
ACT and MS stock compared: price, dividend, valuation and results, from SEC filings.
-0.96%
$190.65
Value $303B
Enact (ACT) has a market value of $6.1B and Morgan Stanley (MS) $303B. Over the last year, with dividends, ACT moved +23.1% and MS +14.7%. The P/E is 9.0 for ACT and 15.3 for MS. Dividend yield: ACT 1.98%, MS 2.26%.
At a glance
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
ACT$6.1B
MS$303B
MS is 50 times ACT
Revenue, 12 months
ACT$1.3B
MS$80.2B
MS is 64 times ACT
Net income, 12 months
ACT$679M
MS$20.5B
MS is 30 times ACT
Operating margin
ACT–
MS–
ROIC
ACT11.2%
MS4.4%
6.8 points apart
P/E
ACT9.0
MS15.3
MS is 1.7 times ACT
Dividend yield
ACT2.0%
MS2.3%
0.3 points apart
5-year return
ACT+158.9%
MS+123.5%
35.4 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
The price over time
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
ACT+158.9%
MS+123.5%
| Period | ACTWith dividends | MSWith dividends |
|---|---|---|
| 1 year since November 12, 2025 | +23.1%Price +20.6% | +14.7%Price +12.2% |
| 3 years since November 13, 2023 | +79.6%+21.5% a yearPrice +63.9% | +176.8%+40.4% a yearPrice +154.1% |
| 5 years since November 12, 2021 | +158.9%+21.0% a yearPrice +106.3% | +123.5%+17.5% a yearPrice +90.9% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
Every figure
As on each company's page. A description, not a recommendation: no one figure says which is better.
ACTEnactMSMorgan Stanley
Valuation
ACTMS| Price | $45.39 | $190.65 |
|---|---|---|
| Market value | $6.1B | $303B |
| Enterprise value (EV) | $6.3B | – |
| P/E | 9.0 | 15.3 |
| P/E, 5-year median | 7.0 | 15.8 |
| P/B | 1.2 | 2.6 |
| EV/EBIT | 7.3 | – |
| Free cash flow yield | 11.7% | – |
Results and growth
ACTMS| Revenue, 12 months | $1.3B | $80.2B |
|---|---|---|
| Net income, 12 months | $679M | $20.5B |
| Free cash flow, 12 months | $713M | – |
| Earnings per share, 12 months | $4.80 | $12.60 |
| Revenue growth, year on year | 2.8% | 14.4% |
| Revenue growth a year, past | +2.2%over 5 years | +7.7%over 5 years |
| EPS growth a year, past | +14.8%over 5 years | +9.6%over 5 years |
Margins and returns on capital
ACTMS| Gross margin | – | – |
|---|---|---|
| Operating margin | – | – |
| Net margin | 54.1% | 25.5% |
| ROIC | 11.2% | 4.4% |
| ROE | 12.8% | 18.0% |
Balance sheet
ACTMS| Cash | $550M | $244B |
|---|---|---|
| Total debt | $746M | $378B |
| Net debt / EBITDA | – | – |
| Interest cover | 17.3× | – |
Dividends and buybacks
ACTMS| Dividend yield | 2.0% | 2.3% |
|---|---|---|
| Dividend per share, 12 months | $0.90 | $4.30 |
| Dividend growth a year, past | – | – |
| Buyback yield | 6.3% | 1.5% |
| Shareholder yield | 8.3% | 3.8% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
Which is bigger, Enact or Morgan Stanley?
By market value, Morgan Stanley ($303B) is about 49.6 times Enact ($6.1B), at today's prices.
How did ACT and MS stock do over the last 5 years?
Since November 12, 2021, ACT's price moved +106.3% and MS's +90.9%. With dividends: ACT +158.9% (+21.0% a year), MS +123.5% (+17.5% a year). Past returns do not predict future ones.
Which pays the higher dividend, ACT or MS?
The dividend yield at today's price is 1.98% for Enact and 2.26% for Morgan Stanley. Over the last twelve months they paid $0.90 and $4.30 per share.
What is the P/E of ACT and MS?
At today's price, the P/E is 9.0 for ACT and 15.3 for MS. The median of the last five years was 7.0 and 15.8, which shows where each stands against its own past.
Which has the higher profit margins, Enact or Morgan Stanley?
Over the last twelve months, the net margin was 54.1% for Enact and 25.5% for Morgan Stanley, and the operating margin – and –. Revenue was $1.3B and $80.2B.
Which is the better investment, Enact or Morgan Stanley?
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
Other comparisons
With each of the two, and with the largest in its sector.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
US stocksThe market today, the sectors, the largest companies and the week's results.The market's sectorsThe 11 sectors side by side: returns, share of the market, median P/E and dividend.Compare stocksTwo companies side by side: price over up to ten years, with and without dividends, and every figure.US dividend stocksEach dividend's yield next to whether the company's cash covers it and whether it was ever cut.
Descriptive data from SEC filings and market prices.